Several KV4.3/KChIP3 channel complex modulators have been proposed in the last years as therapeutic targets to modulate channel gating and promote neuroprotection during HD (Lopez-Hurtado et al., 2019). The gene discussed is KCNIP3; the disease is Huntington disease.